U.S. markets closed

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.48+0.13 (+1.26%)
At close: 4:00PM EST
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
No. of Analysts99910
Avg. Estimate-0.24-0.22-0.86-0.42
Low Estimate-0.27-0.26-1.05-0.72
High Estimate-0.17-0.18-0.680.09
Year Ago EPS-0.35-0.2-1.07-0.86
Revenue EstimateCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
No. of Analysts99911
Avg. Estimate71.83M75.01M312.52M457.77M
Low Estimate69.42M73.42M307.45M362.2M
High Estimate74M77.26M319.38M615M
Year Ago Sales60.52M62.38M260.89M312.52M
Sales Growth (year/est)18.70%20.20%19.80%46.50%
Earnings History3/30/20206/29/20209/29/202012/30/2020
EPS Est.-0.28-0.26-0.22-0.23
EPS Actual-0.35-0.2-0.25-0.27
Difference-0.070.06-0.03-0.04
Surprise %-25.00%23.10%-13.60%-17.40%
EPS TrendCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.24-0.22-0.86-0.42
7 Days Ago-0.21-0.21-0.81-0.39
30 Days Ago-0.2-0.2-0.78-0.31
60 Days Ago-0.19-0.2-0.75-0.31
90 Days Ago-0.18-0.18-0.73-0.29
EPS RevisionsCurrent Qtr. (Mar 2021)Next Qtr. (Jun 2021)Current Year (2021)Next Year (2022)
Up Last 7 Days1221
Up Last 30 Days1221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days5565
Growth EstimatesFOLDIndustrySector(s)S&P 500
Current Qtr.31.40%N/AN/AN/A
Next Qtr.-10.00%N/AN/AN/A
Current Year19.60%N/AN/AN/A
Next Year51.20%N/AN/AN/A
Next 5 Years (per annum)-1.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A